首页> 美国卫生研究院文献>Iranian Biomedical Journal >Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli
【2h】

Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli

机译:包含产肠毒素大肠杆菌大肠杆菌表面抗原3和不稳定B亚基的融合蛋白的免疫原性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Enterotoxigenic Escherichia coli (ETEC) strains are the major causes of diarrheal disease in humans and animals. Colonization factors and enterotoxins are the major virulence factors in ETEC pathogenesis. For the broad-spectrum protection against ETEC, one could focus on colonization factors and non-toxic heat labile as a vaccine candidate. >Methods: A fusion protein is composed of a major fimbrial subunit of coli surface antigen 3, and the heat-labile B subunit (LTB) was constructed as a chimeric immunogen. For optimum level expression of protein, the gene was synthesized with codon bias of E. coli. Also, recombinant protein was expressed in E. coli BL21DE3. ELISA and Western tests were carried out for determination of antigen and specificity of antibody raised against recombinant protein in animals. The anti-toxicity and anti-adherence properties of the immune sera against ETEC were also evaluated. >Results: Immunological analyses showed the production of high titer of specific antibody in immunized mice. The built-in LTB retains native toxin properties which were approved by GM1 binding assay. Pre-treatment of the ETEC cells with anti-sera significantly decreased their adhesion to Caco-2 cells. >Conclusion: The results indicated the efficacy of the recombinant chimeric protein as an effective immunogen inducing strong humoral response. The designated chimer would be an interesting prototype for a vaccine and worthy of further investigation.
机译:>背景:产肠毒素的大肠杆菌(ETEC)菌株是人类和动物腹泻病的主要原因。殖民化因子和肠毒素是ETEC发病机理中的主要毒力因子。对于针对ETEC的广谱保护,人们可以将重点放在定植因子和对疫苗无毒的热毒性上。 >方法:融合蛋白由大肠杆菌表面抗原3的主要纤维亚基组成,并且将不耐热的B亚基(LTB)构建为嵌合免疫原。为了最佳水平表达蛋白质,在大肠杆菌密码子偏向下合成了该基因。另外,重组蛋白在大肠杆菌BL21DE3中表达。进行了ELISA和Western测试以确定动物中针对重组蛋白的抗原和抗体的特异性。还评估了抗ETEC的免疫血清的抗毒性和抗粘附性能。 >结果:免疫学分析显示,免疫小鼠中产生高滴度的特异性抗体。内置的LTB保留了天然毒素的特性,这已通过GM1结合检测得到认可。用抗血清对ETEC细胞进行预处理可显着降低其对Caco-2细胞的粘附力。 >结论:该结果表明重组嵌合蛋白作为诱导强体液反应的有效免疫原的功效。指定的嵌合体将是疫苗的有趣原型,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号